Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome

Critical Care Medicine

Volumn 42, Issue 9, 2014, Pages 2058-2068

  Hsieh, S Jean ^a   Zhuo, Hanjing ^b   Benowitz, Neal L ^b,c   Thompson, B Taylor ^d   Liu, Kathleen D ^b,c   Matthay, Michael A ^b,c   Calfee, Carolyn S ^b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

4 (methylnitrosamino) 1 (3 pyridyl) 1 butanol; acute respiratory distress syndrome; cigarette smoking; lung injury; mortality

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ALCOHOL; BIOLOGICAL MARKER; CIGARETTE SMOKE; HYPERTENSIVE AGENT; SALBUTAMOL;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALCOHOL CONSUMPTION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; INCIDENCE; LABORATORY TEST; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PASSIVE SMOKING; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SMOKING; URINALYSIS;

ACUTE LUNG INJURY; ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; APACHE; COMORBIDITY; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NITROSAMINES; PREVALENCE; PYRIDINES; RESPIRATORY DISTRESS SYNDROME, ADULT; SMOKING; SOCIOECONOMIC FACTORS; TOBACCO SMOKE POLLUTION;

EID: 84906791095     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000418     Document Type: Article

References (49)

1. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al: Acute respiratory distress syndrome: The Berlin definition. JAMA 2012; 307:2526-2533
2. Zambon M, Vincent JL: Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008; 133: 1120-1127
3. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693
4. Mikkelsen ME, Christie JD, Lanken PN, et al: The adult respiratory distress syndrome cognitive outcomes study: Long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med 2012; 185:1307-1315
5. Herridge MS, Tansey CM, Matté A, et al; Canadian Critical Care Trials Group: Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364:1293-1304
6. Dusser DJ, Minty BD, Collignon MA, et al: Regional respiratory clearance of aerosolized 99mTc-DTPA: Posture and smoking effects. J Appl Physiol (1985) 1986; 60:2000-2006
7. Hoshino Y, Mio T, Nagai S, et al: Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. Am J Physiol Lung Cell Mol Physiol 2001; 281:L509-L516
8. Xu H, Ferro TJ, Chu S: Cigarette smoke condensate inhibits ENaC alpha-subunit expression in lung epithelial cells. Eur Respir J 2007; 30:633-642
9. Olivera DS, Boggs SE, Beenhouwer C, et al: Cellular mechanisms of mainstream cigarette smoke-induced lung epithelial tight junction permeability changes in vitro. Inhal Toxicol 2007; 19:13-22
10. Raupach T, Schäfer K, Konstantinides S, et al: Secondhand smoke as an acute threat for the cardiovascular system: A change in paradigm. Eur Heart J 2006; 27:386-392
11. Barnoya J, Glantz SA: Cardiovascular effects of secondhand smoke: Nearly as large as smoking. Circulation 2005; 111:2684-2698
12. Calfee CS, Matthay MA, Eisner MD, et al: Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med 2011; 183:1660-1665
13. Toy P, Gajic O, Bacchetti P, et al; TRALI Study Group: Transfusionrelated acute lung injury: Incidence and risk factors. Blood 2012; 119:1757-1767
14. Diamond JM, Lee JC, Kawut SM, et al; Lung Transplant Outcomes Group: Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187:527-534
15. Bonser RS, Taylor R, Collett D, et al; Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK): Effect of donor smoking on survival after lung transplantation: A cohort study of a prospective registry. Lancet 2012; 380:747-755
16. Iribarren C, Jacobs DR Jr, Sidney S, et al: Cigarette smoking, alcohol consumption, and risk of ARDS: A 15-year cohort study in a managed care setting. Chest 2000; 117:163-168
17. Van Rompaey B, Elseviers MM, Schuurmans MJ, et al: Risk factors for delirium in intensive care patients: A prospective cohort study. Crit Care 2009; 13:R77
18. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease prevention and Health Promotion, Office on Smoking and Health: The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA, Centers for Disease Control and Prevention, 2006
19. Goniewicz ML, Eisner MD, Lazcano-Ponce E, et al: Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob Res 2011; 13:202-208
20. Hecht SS, Hoffmann D: Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988; 9:875-884
21. Benowitz NL, Schultz KE, Haller CA, et al: Prevalence of smoking assessed biochemically in an urban public hospital: A rationale for routine cotinine screening. Am J Epidemiol 2009; 170:885-891
22. Yuan JM, Gao YT, Murphy SE, et al: Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res 2011; 71:6749-6757
23. Hsieh SJ, Ware LB, Eisner MD, et al: Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. Crit Care Med 2011; 39:40-45
24. Goniewicz ML, Havel CM, Peng MW, et al: Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev 2009; 18:3421-3425
25. Matthay MA, Brower RG, Carson S, et al: Randomized, placebocontrolled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011; 184:561-568
26. Rice TW, Wheeler AP, Thompson BT, et al: Initial trophic vs full enteral feeding in patients with acute lung injury: The EDEN randomized trial. JAMA 2012; 307:795-803
27. Jacob P III, Havel C, Lee DH, et al: Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem 2008; 80:8115-8121
28. Reinert DF, Allen JP: The Alcohol Use Disorders Identification Test (AUDIT): A review of recent research. Alcohol Clin Exp Res 2002; 26:272-279
29. Rubinsky AD, Kivlahan DR, Volk RJ, et al: Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol Depend 2010; 108:29-36
30. Moss M, Mannino DM: Race and gender differences in acute respiratory distress syndrome deaths in the United States: An analysis of multiple-cause mortality data (1979-1996). Crit Care Med 2002; 30:1679-1685
31. Stapleton RD, Wang BM, Hudson LD, et al: Causes and timing of death in patients with ARDS. Chest 2005; 128:525-532
32. Clark BJ, Williams A, Feemster LM, et al: Alcohol screening scores and 90-day outcomes in patients with acute lung injury. Crit Care Med 2013; 41:1518-1525
33. Cooke CR, Kahn JM, Caldwell E, et al: Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med 2008; 36:1412-1420
34. Centers for Disease Control and Prevention: Current cigarette smoking prevalence among working adults-United States, 2004-2010. MMWR Morb Mortal Wkly Rep 2011; 60:1305-1309
35. Centers for Disease Control and Prevention: Vital signs: Nonsmokers' exposure to secondhand smoke-United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2010; 59:1141-1146
36. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
37. Seeley E, McAuley DF, Eisner M, et al: Predictors of mortality in acute lung injury during the era of lung protective ventilation. Thorax 2008; 63:994-998
38. Eisner MD: Smoking and adult asthma: A healthy smoker effect? Am J Respir Crit Care Med 2002; 165:1566; author reply 1566-1567
39. Ruiz-Bailén M, de Hoyos EA, Reina-Toral A, et al; ARIAM Group: Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: Results of the ARIAM Register. Chest 2004; 125:831-840
40. Mant J, Murphy M, Rose P, et al: The accuracy of general practitioner records of smoking and alcohol use: Comparison with patient questionnaires. J Public Health Med 2000; 22:198-201
41. Woo JG, Pinney SM: Retrospective smoking history data collection for deceased workers: Completeness and accuracy of surrogate reports. J Occup Environ Med 2002; 44:915-923
42. Agrawal A, Matthay MA, Kangelaris KN, et al: Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med 2013; 187:736-742
43. Sheu CC, Gong MN, Zhai R, et al: Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest 2010; 138:559-567
44. Guidot DM, Modelska K, Lois M, et al: Ethanol ingestion via glutathione depletion impairs alveolar epithelial barrier function in rats. Am J Physiol Lung Cell Mol Physiol 2000; 279:L127-L135
45. Zhang YL, Li QQ, Guo W, et al: Effects of chronic ethanol ingestion on tight junction proteins and barrier function of alveolar epithelium in the rat. Shock 2007; 28:245-252
46. Goniewicz M, Peyton J, Havel C, et al: Application of urine cotinine to NNAL ratio in tobacco smoke exposure assessment. 2009 Joint Conference of Society for Research on Nicotine and Tobacco and SNRT-Europe. Dublin, Ireland; 2009. POS4-78
47. Centers for Disease Control and Prevention: State-Specific Prevalence of Cigarette Smoking and Smokeless Tobacco Use Among Adults-United States, 2010; 59: No. 43. Available at: http://www.cdc.gov/tobacco/data-statistics/mmwrs/ byyear/2010/mm5943a2/highlights.htm. Accessed May 9, 2014
48. Cooke CR, Erickson SE, Watkins TR, et al: Age-, sex-, and race-based differences among patients enrolled versus not enrolled in acute lung injury clinical trials. Crit Care Med 2010; 38:1450-1457
49. Glassberg AE, Luce JM, Matthay MA; National Heart, Lung, and Blood Institute Clinical Trials Network: Reasons for nonenrollment in a clinical trial of acute lung injury. Chest 2008; 134:719-723